Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.
Akasaki Y, Kikuchi T, Homma S, Koido S, Ohkusa T, Tasaki T, Hayashi K, Komita H, Watanabe N, Suzuki Y, Yamamoto Y, Mori R, Arai T, Tanaka T, Joki T, Yanagisawa T, Murayama Y.
Akasaki Y, et al. Among authors: arai t.
Cancer Immunol Immunother. 2016 Dec;65(12):1499-1509. doi: 10.1007/s00262-016-1905-7. Epub 2016 Sep 29.
Cancer Immunol Immunother. 2016.
PMID: 27688162
Free PMC article.
Clinical Trial.